CD1d-restricted T cell activation by nonlipidic small molecules
AUTOR(ES)
Van Rhijn, Ildiko
FONTE
National Academy of Sciences
RESUMO
In addition to NK T cells expressing invariant Vα14 or Vα24 T cell receptors (TCRs), the CD1d-restricted T cell repertoire is comprised of T cells with diverse TCRs that mediate inflammation during autoimmune and infectious disease. Here we describe the isolation of human Vα24– T cells that are activated by antigen and CD1d. Mass spectrometric and NMR studies revealed that the stimulatory compounds were neither peptidic nor lipidic but instead were composed of sulfur and aromatic hydrocarbon rings, corresponding to the general structure of phenyl pentamethyldihydrobenzofuran sulfonates. Studies of the molecular mechanism of T cell activation showed that a clonotypic Vα2/Vβ21 TCR transmitted activating signals, which were highly specific for hydroxylation and methylation patterns at the terminal structures of stimulatory compounds. These studies provide evidence for noninvariant CD1d-restricted T cells in humans and identify the complete molecular structure of a nonlipidic small molecule that activates T cells through an αβ TCR.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=518797Documentos Relacionados
- Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets
- Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells
- Role of CD1d-Restricted NKT Cells in Microbial Immunity
- Adaptability of the semi-invariant natural killer T-cell receptor towards structurally diverse CD1d-restricted ligands
- Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of α-galactosylceramides